March 7 (Reuters) - Valeant Pharmaceuticals (NYSE:VRX) International
Inc VRX.TO VRX.N said it would release preliminary
fourth-quarter results on March 15, followed by a conference
call on the same day.
The Canadian drugmaker, in an announcement last week that
Chief Executive Michael Pearson (LON:PSON) would return from medical leave,
said it would also delay releasing its results, which had been
scheduled for Feb. 29.
"February 29th was my first day back to work following a
two-month medical absence," Pearson said in a statement on
Monday. "Now that I have returned, I have been working
diligently to review the business so that I can share our latest
performance and outlook with shareholders."